Dog · Canis lupus familiaris · typical adult weight 2.00–80.00 kg
Surovetmab is used in dog for Cancer immunotherapy (anti-PD-L1). Routes documented in dog: IV. A typical adult dog weighs 2.00–80.00 kg. ExoticRx lists 1 cited dose rule for Surovetmab in dog, drawn from published veterinary references. Verify against current literature before clinical use.
Trade names: Stelfonta Adjunct
| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| IV | 5–10 mg/kg | q2-3 weeks | Per oncology protocol | Cancer immunotherapy (anti-PD-L1) | Weak | Papich Handbook of Veterinary Drugs, 5th Ed |
Need the exact dose for your patient?
These ranges are per kg. Enter your dog's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
Anti-PD-L1 canine monoclonal antibody checkpoint inhibitor. Blocks PD-1/PD-L1 interaction to restore T-cell mediated anti-tumor immune response.
Investigational/conditionally approved. Immune-mediated adverse events possible. Monitor for autoimmune-like reactions. Dogs only.
Species-specific contraindications and adverse-reaction reports for dog may differ from canine / feline reference data — consult the primary citations listed with each rule.
Why a species-specific page? Surovetmab pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in dog — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.